Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Cell & Gene Therapy

Stem cell research and commercialization in China...

Siranomics Closes $105 Million Funding from China Investors; Plans IPO

Beijing Immunochina Raises $15 Million for CAR-T Portfolio

Qihan Biotech Applies Genome Editing to Create Allogenic Stem Cells

Two China Biopharmas Strike $65 Million Deal for Rights to Cell Therapy

CARsgen Granted US Orphan Drug Status for Claudin18.2 CAR-T Drug

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

ChinaBio Partnering Forum 2020

Content Availbalble Until Dec. 21, 2020